Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 128Esophageal Neoplasms 127Esophageal Squamous Cell Carcinoma 77Adenocarcinoma Of Esophagus 36Pancreatic Neoplasms 30Colorectal Neoplasms 25Carcinoma, Non-Small-Cell Lung 23Breast Neoplasms 22Neoplasms 21Neoplasm Metastasis 19Ovarian Neoplasms 16Melanoma 12Lung Neoplasms 11Carcinoma, Squamous Cell 11Parkinson Disease 4, Autosomal Dominant Lewy Body 10Adenocarcinoma 10Endometrial Neoplasms 9Carcinoma, Renal Cell 9Advanced Gastric Cancer 9Squamous Cell Carcinoma of Head and Neck 8Peritoneal Neoplasms 8Colonic Neoplasms 8Carcinoma, Ovarian Epithelial 8Anus Neoplasms 8Digestive System Neoplasms 7Prostatic Neoplasms 6Cholangiocarcinoma 6Biliary Tract Neoplasms 6Uterine Cervical Neoplasms 5Sarcoma 5

Interventions

camrelizumab 2Radiation 2sintilimab 1Tumor Burden 1Pyloromyotomy 1Paclitaxel 1Ocoxin 1Itraconazole 1Fluorouracil 1Esophagectomy 1Erlotinib Hydrochloride 1Cisplatin 1Botulinum Toxins, Type A 1Blood Specimen Collection 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Diseases × Paclitaxel × Gastrointestinal × Clear all
NCT03748134 2023-10-24

Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )

Innovent Biologics (Suzhou) Co. Ltd.

Phase 3 Completed
746 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Diseases, Esophageal Neoplasms, Gastrointestinal Diseases, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡